Metraipolis › archive › dc_fb2a3cd753dc

Loss of miR-122 promotes cell migration and poor prognosis in triple-negative breast cancer treated by neoadjuvant chemotherapy — Europe PMC PMID:41123849

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41123849
DOI
10.1007/s12094-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-09T03:52:54.063Z
SHA-256 of the archived text
f24347302a2a7a7fc057d02b14fcc9eca26b2d7b63fc2f452e93c0b9334701ed
Stable URL of this page
https://metraipolis.com/documento/dc_fb2a3cd753dc

How to cite

Loss of miR-122 promotes cell migration and poor prognosis in triple-negative breast cancer treated by neoadjuvant chemotherapy — Europe PMC PMID:41123849 — Europe PMC (en), https://europepmc.org/article/MED/41123849 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb2a3cd753dc (Metraipolis archive dc_fb2a3cd753dc, sha256 f24347302a2a7a7fc057d02b14fcc9eca26b2d7b63fc2f452e93c0b9334701ed)
BibTeX
@misc{dcfb2a3cd753dc,
  title = {Loss of miR-122 promotes cell migration and poor prognosis in triple-negative breast cancer treated by neoadjuvant chemotherapy — Europe PMC PMID:41123849},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41123849},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb2a3cd753dc; sha256 f24347302a2a7a7fc057d02b14fcc9eca26b2d7b63fc2f452e93c0b9334701ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41123849. Agents can read the archived copy with the MCP tool read_document.